Avid Bioservices 

€8.25
15
+€0+0% 今天

統計

當日最高
8.25
當日最低
8.25
52週最高
-
52週最低
-
成交量
0
平均成交量
-
市值
373.42M
市盈率
54.42
股息收益率
-
股息
-

即將到來

收益

3Dec預期
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Q2 2024
下一個
-1.81
-1.22
-0.63
-0.03
預期每股收益
-0.088353525
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 TEHP.F 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.
Show more...
首席執行官
Mr. Nicholas Stewart Green B.Sc., MBA
員工
371
國家
US
ISIN
US05368M1062
WKN
000A2JBKV

上市公司